Experimental Biology And Medicine | Finanzwire

Basculer en Français

8295	Companies
114833	Keywords
55274	Articles
62430	Press releases

Headlines Articles Press releases Experimental Biology And Medicine

Home
Companies
Experimental Biology And Medicine

BRIEF

published on 06/18/2024 at 15:05, 5 months 2 days ago

New Study Examines How Topical Naltrexone Restores Tear Production in Diabetic Dry Eye

Diabetic Dry Eye Naltrexone Tear Production OGF-OGFr Pathway Ocular Complications
PRESS RELEASE

published on 06/18/2024 at 15:00, 5 months 2 days ago

New Study Examines How Topical Naltrexone Restores Tear Production in Diabetic Dry Eye
Study led by Dr. Pat McLaughlin reveals topical naltrexone's effectiveness in reversing dry eye in diabetic rats. Findings point to OGF-OGFr pathway blockade as a promising treatment approach

Diabetes Experimental Biology And Medicine Naltrexone OGF-OGFr Pathway Dry Eye
BRIEF

published on 04/03/2024 at 15:05, 7 months 17 days ago

HTERT Vaccine Shows Promise in Therapy-Resistant Cancer Patients, Study Finds

Cancer Immunotherapy HTERT Vaccination Therapy-resistant Cancer Immune Response King's College London
PRESS RELEASE

published on 04/03/2024 at 15:00, 7 months 17 days ago

Study Shows hTERT Vaccination Induces Immunological Responses and Prevents Progression in a Subset of Therapy-Resistant Poor Prognosis Cancer Patients
A Phase 1 clinical trial led by James Spicer at King's College London showcases promising developments in immune therapy for solid tumours via hTERT vaccination. Published in Experimental Biology and Medicine

Solid Tumors Clinical Trial HTERT Vaccination Immune Therapy Experimental Biology And Medicine

Accesswire

Published on 11/21/2024 at 10:03, 38 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 41 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 41 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 6 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 16 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 10:30, 11 minutes ago

MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 36 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 39 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 41 minutes ago

Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 41 minutes ago

Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV

Les Echos

Published on 11/21/2024 at 06:58, 3 hours 43 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 21 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 16 hours 56 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 16 hours 56 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 2 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE